Phillip G. Febbo is a Chief Scientific & Med Officer who has filed 46 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing shows the insider had shares withheld for taxes covering $178.3K of VCYT on Jun 4, 2026. Across all open-market trades the lifetime net is −$3.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.